SLP - Simulations Plus Inc Stock Price, Fair Value and News

44.45USD-0.25 (-0.56%)Market Closed

Market Summary

USD44.45-0.25

Market Closed

-0.56%

SLP Alerts

1 major insider sales recently.

SLP Stock Price

View Fullscreen

SLP RSI Chart

SLP Valuation

Market Cap

893.3M

Price/Earnings (Trailing)

84.95

Price/Sales (Trailing)

13.81

EV/EBITDA

50.83

Price/Free Cashflow

52.52

SLP Price/Sales (Trailing)

SLP Profitability

Operating Margin

75.14%

EBT Margin

19.59%

Return on Equity

5.94%

Return on Assets

5.42%

Free Cashflow Yield

1.9%

SLP Fundamentals

SLP Revenue

Revenue (TTM)

64.7M

Rev. Growth (Yr)

16.22%

Rev. Growth (Qtr)

26.24%

SLP Earnings

Earnings (TTM)

10.5M

Earnings Growth (Yr)

-3.47%

Earnings Growth (Qtr)

107.15%

Breaking Down SLP Revenue

Last 7 days

-6.5%

Last 30 days

7.0%

Last 90 days

18.0%

Trailing 12 Months

5.6%

How does SLP drawdown profile look like?

SLP Financial Health

Current Ratio

8.81

SLP Investor Care

Dividend Yield

0.54%

Dividend/Share (TTM)

0.24

Buy Backs (1Y)

0.06%

Diluted EPS (TTM)

0.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	64.7M	0	0	0
2023	54.4M	55.7M	59.6M	62.1M
2022	49.8M	52.0M	53.9M	53.5M
2021	45.7M	46.2M	46.5M	48.2M
2020	37.7M	40.1M	41.6M	42.9M
2019	31.2M	32.6M	34.0M	35.8M
2018	27.4M	29.2M	29.7M	30.1M
2017	21.1M	21.8M	24.1M	25.8M
2016	19.7M	19.7M	20.0M	20.6M
2015	14.4M	16.6M	18.3M	19.1M
2014	10.4M	11.0M	11.5M	12.9M
2013	9.8M	10.1M	10.1M	10.4M
2012	9.1M	9.2M	9.4M	9.5M
2011	0	0	8.7M	8.9M
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Simulations Plus Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 01, 2024	woltosz walter s	sold	-798,867	39.9433	-20,000	-
Mar 01, 2024	woltosz walter s	sold	-828,240	41.412	-20,000	-
Feb 02, 2024	woltosz walter s	sold	-39,710	37.64	-1,055	-
Feb 01, 2024	woltosz walter s	sold	-720,237	38.0173	-18,945	-
Feb 01, 2024	evans sharlene	acquired	-	-	792	-
Feb 01, 2024	lavange lisa	acquired	-	-	792	-
Feb 01, 2024	woltosz walter s	acquired	-	-	792	-
Feb 01, 2024	weiner daniel l	acquired	-	-	792	-
Feb 01, 2024	paglia john kenneth	acquired	-	-	792	-
Jan 04, 2024	paglia john kenneth	sold	-43,740	43.74	-1,000	-

Which funds bought or sold SLP recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 17, 2024	Hennion & Walsh Asset Management, Inc.	added	49.04	398,740	1,475,020	0.08%
Apr 16, 2024	Kopion Asset Management, LLC	added	144	3,402,600	5,491,230	4.21%
Apr 15, 2024	Sunbelt Securities, Inc.	added	2,519	21,692	22,632	-%
Apr 12, 2024	FIRST FINANCIAL CORP /IN/	new	-	1,399	1,399	-%
Apr 12, 2024	HARBOR INVESTMENT ADVISORY, LLC	unchanged	-	-1,440	16,460	-%
Apr 12, 2024	MILLER HOWARD INVESTMENTS INC /NY	added	0.29	-23,927	283,729	0.01%
Apr 11, 2024	CONGRESS ASSET MANAGEMENT CO /MA	added	34.65	1,357,410	7,056,800	0.05%
Apr 09, 2024	MASSMUTUAL TRUST CO FSB/ADV	unchanged	-	-11.00	123	-%
Apr 05, 2024	CWM, LLC	added	8.00	-	1,000	-%
Apr 05, 2024	GAMMA Investing LLC	added	453	2,470	2,963	-%

Are Funds Buying or Selling SLP?

Are funds buying SLP calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SLP

No. of Funds

SLP Alerts

1 major insider sales recently.

Unveiling Simulations Plus Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	5.63%	1,122,469	SC 13G/A
Feb 12, 2024	neuberger berman group llc	6.61%	1,320,723	SC 13G/A
Jan 23, 2024	blackrock inc.	12.7%	2,542,709	SC 13G/A
Jan 05, 2024	conestoga capital advisors, llc	12.1%	2,412,465	SC 13G/A
Feb 10, 2023	neuberger berman group llc	7.48%	1,520,778	SC 13G/A
Feb 09, 2023	vanguard group inc	5.51%	1,119,112	SC 13G/A
Jan 23, 2023	blackrock inc.	12.8%	2,606,308	SC 13G/A
Jan 19, 2023	conestoga capital advisors, llc	11.36%	2,306,377	SC 13G/A
Feb 11, 2022	neuberger berman group llc	8.33%	1,681,229	SC 13G/A
Jan 27, 2022	blackrock inc.	12.0%	2,420,327	SC 13G/A

Recent SEC filings of Simulations Plus Inc

View All Filings

Date Filed	Form Type	Document
Apr 05, 2024	10-Q	Quarterly Report
Apr 03, 2024	8-K	Current Report
Apr 02, 2024	4	Insider Trading
Apr 01, 2024	144	Notice of Insider Sale Intent
Mar 29, 2024	4	Insider Trading
Mar 06, 2024	S-8	Employee Benefits Plan
Mar 05, 2024	4	Insider Trading
Feb 13, 2024	8-K	Current Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 12, 2024	8-K	Current Report

Peers (Alternatives to Simulations Plus Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	441.4B	371.6B	-1.70%	-5.10%	19.72	1.19	14.64%	11.24%
CI	101.2B	195.3B	-1.86%	33.27%	18.83	0.52	8.17%	-20.79%
CVS	86.3B	357.8B	-11.58%	-9.18%	10.33	0.24	10.95%	93.52%
HCA	82.3B	65.0B	-4.91%	14.61%	15.7	1.27	7.86%	-7.11%
CNC	38.5B	154.0B	-6.56%	4.41%	14.25	0.25	6.54%	124.79%
DVA	11.2B	12.1B	-6.85%	52.87%	16.19	0.92	4.57%	23.40%
UHS	11.1B	14.3B	-9.76%	16.96%	15.45	0.78	6.59%	6.24%
MID-CAP
CHE	9.1B	2.3B	-6.80%	8.45%	33.52	4.03	6.06%	9.17%
ACHC	6.5B	2.9B	-10.10%	-6.68%	-299.22	2.21	12.20%	-107.93%
AMN	2.1B	3.8B	-10.37%	-33.80%	10.13	0.56	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.48%	-7.06%	34.15	1.5	21.19%	34.42%
SMALL-CAP
ADUS	1.6B	1.1B	-4.65%	-11.57%	25.08	1.48	11.31%	35.83%
BKD	1.2B	3.0B	5.90%	51.29%	-6.47	0.41	6.74%	20.73%
BEAT	56.9M	-	-6.90%	0.47%	-3.88	-	-	-12.94%
AMS	18.9M	21.3M	15.18%	4.04%	35.51	0.89	8.00%	-62.25%

Simulations Plus Inc News

Latest updates

Simulations Plus Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	26.2%	18.00	15.00	16.00	16.00	16.00	12.00	12.00	15.00	15.00	12.00	10.00	13.00	13.00	11.00	10.00	12.00	10.00	9.00	8.00	10.00	8.00
Cost Of Revenue	9.3%	5.00	5.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	2.00	3.00	2.00	3.00	3.00	3.00	3.00	2.00	2.00	2.00
Gross Profit	34.3%	13.00	10.00	12.00	13.00	13.00	9.00	9.00	12.00	12.00	10.00	7.00	10.00	10.00	8.00	7.00	10.00	8.00	7.00	6.00	8.00	6.00
Operating Expenses	-1.2%	9.00	9.00	13.00	9.00	9.00	8.00	8.00	7.00	6.00	6.00	7.00	6.00	7.00	5.00	5.00	6.00	5.00	4.00	4.00	4.00	4.00
S&GA Expenses	-2.9%	6.00	6.00	12.00	8.00	8.00	6.00	8.00	7.00	6.00	5.00	6.00	5.00	5.00	4.00	4.00	5.00	4.00	4.00	3.00	3.00	3.00
R&D Expenses	7.8%	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
EBITDA Margin	-1.9%	0.26*	0.27*	0.26*	0.29*	0.29*	0.31*	0.35*	0.35*	0.36*	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	-	-	-0.11	0.00	0.00
Income Taxes	165.3%	1.00	0.00	-0.68	1.00	1.00	0.00	1.00	1.00	1.00	1.00	-0.13	1.00	0.00	1.00	-0.15	1.00	1.00	1.00	-0.07	1.00	1.00
Earnings Before Taxes	118.3%	5.00	2.00	0.00	5.00	5.00	2.00	1.00	5.00	6.00	4.00	0.00	4.00	3.00	3.00	2.00	4.00	3.00	3.00	2.00	4.00	3.00
EBT Margin	-2.5%	0.20*	0.20*	0.20*	0.22*	0.23*	0.24*	0.28*	0.28*	0.28*	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	107.1%	4.00	2.00	1.00	4.00	4.00	1.00	1.00	4.00	4.00	3.00	0.00	4.00	3.00	2.00	2.00	3.00	2.00	2.00	2.00	3.00	2.00
Net Income Margin	-5.3%	0.16*	0.17*	0.17*	0.19*	0.19*	0.20*	0.23*	0.23*	0.23*	-	-	-	-	-	-	-	-	-	-	-	-
Free Cashflow	3219.1%	5.00	0.00	3.00	9.00	5.00	5.00	8.00	4.00	2.00	-	-	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	4.4%	194	186	186	179	173	190	188	186	185	181	180	179	176	170	168	62.00	49.00	48.00	45.00	46.00	43.00
Current Assets	-1.3%	128	130	130	137	131	149	147	145	144	140	139	139	136	131	129	22.00	25.00	23.00	21.00	21.00	19.00
Cash Equivalents	-6.9%	37.00	40.00	58.00	55.00	39.00	49.00	52.00	42.00	60.00	42.00	37.00	59.00	42.00	28.00	49.00	7.00	12.00	13.00	11.00	10.00	10.00
Net PPE	73.1%	1.00	0.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	2.00	2.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	0%	19.00	19.00	19.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	10.00	10.00	10.00	10.00	10.00
Liabilities	26.0%	17.00	13.00	16.00	10.00	9.00	10.00	10.00	9.00	12.00	13.00	14.00	14.00	14.00	12.00	12.00	15.00	8.00	9.00	8.00	10.00	10.00
Current Liabilities	69.2%	15.00	9.00	12.00	9.00	6.00	8.00	8.00	6.00	9.00	10.00	12.00	7.00	7.00	5.00	6.00	8.00	5.00	6.00	5.00	5.00	5.00
Shareholder's Equity	2.7%	177	172	170	169	27.00	180	139	178	37.00	135	166	165	131	0.00	0.00	47.00	16.00	23.00	22.00	36.00	34.00
Retained Earnings	10.9%	29.00	26.00	25.00	26.00	27.00	40.00	40.00	40.00	37.00	34.00	32.00	33.00	31.00	29.00	27.00	26.00	24.00	23.00	22.00	21.00	19.00
Additional Paid-In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	129	20.00	16.00	16.00	15.00	15.00	14.00
Shares Outstanding	0.1%	20.00	20.00	20.00	20.00	20.00	20.00	20.00	20.00	20.00	-	-	-	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	604	-	-	-	618	-	-	-	1,111	-	-	-	413	-	-	-	247

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	3486.4%	5,810	162	3,060	8,548	5,541	4,707	7,927	3,794	2,597	3,582	8,273	4,296	1,301	5,333	4,808	2,279	1,191	2,634	4,123	1,826	3,076
Share Based Compensation	31.1%	1,785	1,362	1,280	1,248	1,264	1,036	758	766	791	722	709	705	804	532	505	287	345	367	351	225	209
Cashflow From Investing	55.4%	-7,516	-16,864	520	7,919	5,349	-6,422	2,303	-17,087	17,138	1,951	-27,607	12,761	13,978	-25,874	-67,994	-6,311	-661	-539	-467	-464	-607
Cashflow From Financing	-1.9%	-1,052	-1,032	-1,188	-628	-20,990	-460	-1,016	-4,727	-1,042	-837	-2,493	-631	-545	-1,015	105,040	-862	-892	-920	-2,529	-947	-1,926
Dividend Payments	0.2%	1,198	1,196	1,196	1,200	1,195	1,218	1,214	1,212	1,211	1,209	1,208	1,207	1,201	1,195	1,069	1,066	1,059	1,056	1,052	1,051	1,049
Buy Backs	-	-	-	-	4,000	16,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

SLP Income Statement

2024-02-29

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Revenues
Total revenues	$ 18,305	$ 15,750	$ 32,805	$ 27,714
Cost of revenues
Total cost of revenues	5,084	2,620	9,736	5,291
Gross profit	13,221	13,130	23,069	22,423
Operating expenses
Research and development	1,312	1,317	2,529	2,483
Sales and marketing	1,949	1,730	3,938	3,215
General and administrative	5,518	6,049	11,200	11,813
Total operating expenses	8,779	9,096	17,667	17,511
Income from operations	4,442	4,034	5,402	4,912
Other Income and Expenses [Abstract]
Other income	810	1,034	2,256	1,774
Income before income taxes	5,252	5,068	7,658	6,686
Provision for income taxes	(1,223)	(894)	(1,684)	(1,267)
Net income	$ 4,029	$ 4,174	$ 5,974	$ 5,419
Earnings per share
Earnings per share, basic (in usd per share)	$ 0.20	$ 0.21	$ 0.30	$ 0.27
Earnings per share, diluted (in usd per share)	$ 0.20	$ 0.20	$ 0.29	$ 0.26
Weighted-average common shares outstanding
Weighted average number of shares outstanding, basic (in shares)	19,975	20,112	19,961	20,200
Weighted average number of shares outstanding, diluted (in shares)	20,315	20,529	20,288	20,657
Other comprehensive (loss) income, net of tax
Foreign currency translation adjustments	$ (15)	$ (23)	$ (69)	$ 30
Comprehensive income	4,014	4,151	5,905	5,449
Software
Revenues
Total revenues	11,614	10,487	19,203	16,561
Cost of revenues
Total cost of revenues	1,348	843	2,339	1,728
Services
Revenues
Total revenues	6,691	5,263	13,602	11,153
Cost of revenues
Total cost of revenues	$ 3,736	$ 1,777	$ 7,397	$ 3,563

SLP Balance Sheet

2024-02-29

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
Current assets
Cash and cash equivalents	$ 37,031	$ 57,523
Accounts receivable, net of allowance for credit losses of $30 and $46	13,114	10,201
Prepaid income taxes	1,364	804
Prepaid expenses and other current assets	4,975	3,904
Short-term investments	71,473	57,940
Total current assets	127,957	130,372
Long-term assets
Capitalized computer software development costs, net of accumulated amortization of $17,962 and $17,199	12,333	11,335
Property and equipment, net	843	671
Operating lease right-of-use assets	1,062	1,247
Goodwill	19,099	19,099
Long-term investments	9,024	0
Deferred tax assets	2,323	1,438
Other assets	524	425
Total assets	193,973	186,101
Current liabilities
Accounts payable	360	144
Accrued compensation	3,184	4,392
Accrued expenses	2,992	659
Contracts payable	5,110	3,250
Operating lease liability - current portion	425	442
Deferred revenue	2,457	3,100
Total current liabilities	14,528	11,987
Long-term liabilities
Operating lease liability	607	755
Contracts payable – net of current portion	1,800	3,330
Total liabilities	16,935	16,072
Commitments and contingencies	0	0
Shareholders' equity
Preferred stock, $0.001 par value — 10,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.001 par value and additional paid-in capital —50,000,000 shares authorized; 19,983,703 and 19,937,961 shares issued and outstanding	148,472	144,974
Retained earnings	28,776	25,196
Accumulated other comprehensive loss	(210)	(141)
Total shareholders' equity	177,038	170,029
Total liabilities and shareholders' equity	193,973	186,101
Intellectual property
Long-term assets
Intellectual property and other intangible assets, net of accumulated amortization	7,873	8,689
Other Intangible Assets
Long-term assets
Intellectual property and other intangible assets, net of accumulated amortization	$ 12,935	$ 12,825

About Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems toxicology software; NAFLDsym; IPFsym; RENAsym; IPFsym; and MITOsym. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was incorporated in 1996 and is headquartered in Lancaster, California.

WEBSITE	simulations-plus.com
INDUSTRY	Healthcare Plans
EMPLOYEES	157

Simulations Plus Inc Frequently Asked Questions

What is the ticker symbol for Simulations Plus Inc? What does SLP stand for in stocks?

SLP is the stock ticker symbol of Simulations Plus Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Simulations Plus Inc (SLP)?

As of Wed Apr 17 2024, market cap of Simulations Plus Inc is 893.33 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SLP stock?

You can check SLP's fair value in chart for subscribers.

What is the fair value of SLP stock?

You can check SLP's fair value in chart for subscribers. The fair value of Simulations Plus Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Simulations Plus Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SLP so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Simulations Plus Inc a good stock to buy?

The fair value guage provides a quick view whether SLP is over valued or under valued. Whether Simulations Plus Inc is cheap or expensive depends on the assumptions which impact Simulations Plus Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SLP.

What is Simulations Plus Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, SLP's PE ratio (Price to Earnings) is 84.95 and Price to Sales (PS) ratio is 13.81. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SLP PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Simulations Plus Inc's stock?

In the past 10 years, Simulations Plus Inc has provided 0.239 (multiply by 100 for percentage) rate of return.